Evidence map›Paper›PMID 20675597›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

Brandon Renner, Kathrin Coleman, Ryan Goldberg, Claudia Amura, Amanda Holland-Neidermyer, Kathryn Pierce, Heather N Orth, Hector Molina, Viviana P Ferreira, Claudio Cortes and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Annexin A2 Enhances Complement Activation by Inhibiting Factor H.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  13. Review
  14. Article
  15. Article
  16. Complement as a multifaceted modulator of kidney transplant injury.The Journal of clinical investigation · 2014
    Review
  17. Review
  18. Cyclosporine induces endothelial cell release of complement-activating microparticles.Journal of the American Society of Nephrology : JASN · 2013
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Brandon RennerDepartment of Medicine, University of Colorado Denver School of Medicine, Denver, CO 80045, USA.
Kathrin Coleman
Ryan Goldberg
Claudia Amura
Amanda Holland-Neidermyer
Kathryn Pierce
Heather N Orth
Hector Molina
Viviana P Ferreira
Claudio Cortes
Michael K Pangburn
V Michael Holers
Joshua M Thurman
University of Denver · USUniversity of Toledo Medical Center · USThe University of Texas Health Science Center at Tyler · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

The Complement System and Ischemic Acute Renal FailureR01DK076690 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Joshua M Thurman · 2008 to 2026
$6.6M
MOUSE MEMBRANE RCA PROTEINS IN THE IMMUNE RESPONSER01AI031105 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 1993 to 2008
$2.6M
REGULATION OF COMPLEMENT BY MEMBRANE PROTEINSR01DK035081 · NIDDK · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI PANGBURN, MICHAEL K. · 1986 to 2011
$2.5M
ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENTR37DK035081 · NIDDK · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI PANGBURN, MICHAEL K. · 1993 to 2000
$206k
Complement Activation and Renal Ischemia/Reperfusion InjuryR03DK077661 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI THURMAN, JOSHUA M · 2007 to 2008
$144k
NIAID NIH HHS AI311052NIAID NIH HHS R01 AI031105NIDDK NIH HHS DK035081NIDDK NIH HHS DK076690NIDDK NIH HHS DK77661NIDDK NIH HHS R01 DK035081NIDDK NIH HHS R01 DK076690NIDDK NIH HHS R03 DK077661NIDDK NIH HHS R37 DK035081
6 · The paper itself

Abstract

Congenital and acquired deficiencies of complement regulatory proteins are associated with pathologic complement activation in several renal diseases. To elucidate the mechanisms by which renal tubular epithelial cells (TECs) control the complement system, we examined the expression of complement regulatory proteins by the cells. We found that Crry is the only membrane-bound complement regulator expressed by murine TECs, and its expression is concentrated on the basolateral surface. Consistent with the polarized localization of Crry, less complement activation was observed when the basolateral surface of TECs was exposed to serum than when the apical surface was exposed. Furthermore, greater complement activation occurred when the basolateral surface of TECs from Crry(-/-)fB(-/-) mice was exposed to normal serum compared with TECs from wild-type mice. Complement activation on the apical and basolateral surfaces was also greater when factor H, an alternative pathway regulatory protein found in serum, was blocked from interacting with the cells. Finally, we injected Crry(-/-)fB(-/-) and Crry(+/+)fB(-/-) mice with purified factor B (an essential protein of the alternative pathway). Spontaneous complement activation was seen on the tubules of Crry(-/-)fB(-/-) mice after injection with factor B, and the mice developed acute tubular injury. These studies indicate that factor H and Crry regulate complement activation on the basolateral surface of TECs and that factor H regulates complement activation on the apical surface. However, congenital deficiency of Crry or reduced expression of the protein on the basolateral surface of injured cells permits spontaneous complement activation and tubular injury.

Indexed as

AnimalsCells, CulturedComplement Factor HComplement Inactivator ProteinsComplement Pathway, AlternativeEpithelial CellsFemaleKidney TubulesMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutProtein BindingReceptors, ComplementReceptors, Complement 3bComplement Factor HComplement Inactivator ProteinsCr1l protein, mouseMembrane ProteinsReceptors, ComplementReceptors, Complement 3b

Identifiers

PMID20675597
PMCPMC3133690
OpenAlexW2118763992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.